Pall Corp. To Buy ForteBio - Quick Facts

Pall Appoints Larry Kingsley As Interim CFO - Quick Facts

Pall Q2 13 Earnings Conference Call At 8:30 AM ET

Pall Q2 Profit Down

Trade PLL now with

12/19/2011 2:08 AM ET

Pall Corp. (PLL: Quote) said it has signed a definitive merger agreement to buy ForteBio, Inc., a provider of advanced analytical systems that accelerate the discovery and development of biotech drugs. Terms of the deal were not disclosed.

Pall expects the transaction to close by February of 2012. Upon closing, ForteBio will become a wholly-owned subsidiary of Pall Corp. In the short term, the impact to Pall's results of operations will be immaterial.

Click here to receive FREE breaking news email alerts for Pall Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 69 Articles

Editors Pick

German Business Morale Improves For First Time In 3 Months

Sentiment among German companies strengthened in May for the first time since February due to an improvement in current conditions, indicating that the economy remains on track despite a challenging environment. Moreover, the GfK survey forecast German optimism to reach its highest level in more than five years.

Germany Skirts Recession In Q1 As Consumer Spending Recovers

A rebound in consumer spending helped the German economy thwart recession in the first quarter of 2013, detailed data from the Federal Statistical Office revealed Friday. However, the continued fall in firms' fixed asset investment and extreme weather conditions stifled the recovery. Market research group GfK predicts further increase in consumer confidence in June.

Gap Profit Climbs 43%

Gap Inc. Thursday after the markets closed that its first quarter profit rose 43% from last year, helped by higher sales and improved margins. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company eaffirmed its fiscal year 2013 earnings outlook, which is below analysts' current consensus estimate.